Business
Charlotte's Web's CW Labs Announce New Scientific Collaboration Researching Hemp CBD Efficacy
Charlotte's Web's CW Labs Announce New Scientific Collaboration Researching Hemp CBD Effi...
About this update from Charlotte's Web Holdings, Inc.
[{"type":"text","content":"\n \n \n \n Charlotte's Web's CW Labs Announce New Scientific Collaboration Researching Hemp CBD Efficacy\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n Harvard Medical School's\n \n Dr.\n \n Staci Gruber\n \n , Ph.D. is lead investigator\n \n \n \n \n BOULDER, Colo.\n \n ,\n \n Feb. 24, 2021\n \n /CNW/ - (TSX: CWEB) (OTCQX: CWBHF)\n \n Charlotte's\n \n Web Holdings, Inc. (\"\n \n Charlotte's\n \n Web\" or the \"Company\"), the market leader in hemp CBD wellness products, today announced a long-term scientific collaboration between McLean Hospital, a\n \n Harvard Medical School\n \n affiliate, and the Company.  Funding and product support are provided by the CW Labs division of\n \n Charlotte's\n \n Web Inc.\n \n \n \n \n \n \n \n \n \n Two distinct clinical trials will be overseen by lead researcher/investigator Dr.\n \n Staci A. Gruber\n \n , Ph. D, Associate Professor of Psychiatry at\n \n Harvard Medical School\n \n and Director of the MIND program at McLean Hospital in\n \n Belmont, Mass.\n \n These two studies will investigate the efficacy of a custom-formulated, hemp-derived high-CBD product. Clinical trial results are to be published in 2022. Dr. Gruber is also conducting a number of other studies, including a longitudinal observational study of Veterans who use a\n \n Charlotte's\n \n Web product.\n \n \n Dr. Gruber's Marijuana Investigations for Neuroscientific Discovery (MIND) Program, established in 2014, is the first of its kind, and is dedicated to studying the long-term impact of cannabis and cannabinoids for medical and adult use which utilizes various clinical and cognitive tools as well as multimodal neuroimaging techniques.\n \n \n \"We are honored to be working with Dr. Gruber,\n \n Harvard Medical School\n \n and McLean Hospital on these important clinical trials,\" said\n \n Tim Orr\n \n , President of\n \n Charlotte's\n \n Web's CW Labs divison. \"\n \n Charlotte's\n \n Web remains dedicated to supporting third-party research on hemp CBD investigated by some...